Managing Medicare's HIV caseload in the era of suppressive therapy

American Journal of Public Health

Volumn 97, Issue 6, 2007, Pages 1053-1059

  Gilden, David E ^a   Kubisiak, Joanna M ^a   Gilden, Daniel M ^a  

^a JEN Associates Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CONTROLLED STUDY; DATA BASE; FEMALE; HEALTH CARE COST; HEART DISEASE; HOSPITAL BILLING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; MANAGED CARE; MEDICARE; MORBIDITY; MORTALITY; MYCOSIS; PREVALENCE; RACE DIFFERENCE; SEX DIFFERENCE; TREATMENT OUTCOME; CHRONIC DISEASE; DISABLED PERSON; ECONOMICS; ETHNOLOGY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; MIDDLE AGED; REGRESSION ANALYSIS; STATISTICS; UNITED STATES;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CHRONIC DISEASE; DISABLED PERSONS; FEMALE; HIV INFECTIONS; HUMANS; MALE; MEDICARE; MIDDLE AGED; REGRESSION ANALYSIS; UNITED STATES;

EID: 34250808958     PISSN: 00900036     EISSN: 15410048     Source Type: Journal    
DOI: 10.2105/AJPH.2005.063636     Document Type: Article

References (20)

1. Centers for Disease Control and Prevention. HIV/AIDS Surveillance Report. 2004;16. Available at: http://www.cdc.gov/hiv/stats/hasrlink.htm. Accessed January 3, 2006.
2. Centers for Disease Control and Prevention. HIV/AIDS Surveillance Report. 1999;11. Available at: http://www.cdc.gov/hiv/stats/hasrlink.htm. Accessed January 3, 2006.
3. Osmond D, Charlebois E, Lang W, Shiboski S, Moss A. Changes in AIDS survival time in two San Francisco cohorts of homosexual men, 1983 to 1993. JAMA. 1994;271:1083-1087.
4. Mocroft A, Youle M, Morcinek J, et al. Survival after diagnosis of AIDS: a prospective observational study of 2625 patients. BMJ. 1997;314:409-413.
5. Murphy EL, Collier AC, Kalish LA, et al. Highly active antiretroviral therapy decreases mortality and morbidity in patients with advanced HIV disease. Ann Intern Med. 2001;135:17-26.
6. Fasciano NJ, Thornton CV, Turner BJ, Bencio DS. Profile of Medicare Beneficiaries with AIDS: Application of an AIDS Case-Finding Algorithm. Princeton, NJ: Mathematica Policy Research; 1999.
7. Goldman DP, Leibowitz AA, Joyce GF, et al. Insurance status of HIV-infected adults in the post-HAART era: evidence from the United States. Appl Health Econ Health Policy. 2003;2:85-90.
8. International Classification of Diseases, Ninth Revision. Geneva, Switzerland: World Health Organization; 1980.
9. Centers for Medicare and Medicaid Services. 2003 data compendium. Available at: http://www.cms.hhs.gov/DataCompendium. Accessed January 5, 2006.
10. Centers for Medicare and Medicaid Services. Statistical supplement 2003. Available at: http://www.cms.hhs.gov/MedicareMedicaidStatSupp/ 02_2003_Statistical_Suppl.asp#TopOfPage. Accessed January 5, 2006.
11. Fleishman JA, Gebo KA, Reilly ED, et al. Hospital and outpatient health services utilization among HIV-infected adults in care 2000-2002. Med Care. 2005;43:40-52.
12. Chen RY, Accortt NA, Westfall AO, et al. Distribution of health care expenditures for HIV-infected patients. Clin Infect Dis. 2006;42:1003-1010.
13. Levy AR, James D, Johnston KM, et al. The direct costs of HIV/AIDS care. Lancet Infect Dis. 2006;6:171-177.
14. Grinspoon S, Carr A. Cardiovascular risk and body-fat abnormalities in HIV-infected adults. N Engl J Med. 2005;352:48-62.
15. Ross MJ, Klotman PE. HIV-associated nephropathy. AIDS. 2004;18:1089-1099.
16. Szczech LA, Gupta SK, Habash R, et al. The clinical epidemiology and course of the spectrum of renal diseases associated with HIV infection. Kidney Int. 2004;66:1145-1152.
17. Fleishman JA, Hellinger FH. Recent trends in HIV-related inpatient admissions 1996-2000: a 7-state study. J Acquir Immune Defic Syndr. 2003;34:102-110.
18. Steinbrook R. Providing antiretroviral therapy for HIV infection. N Engl J Med. 2001;344:844-846.
19. Krentz HB, Auld MC, Gill MJ, HIV Economic Study Group. The changing direct costs of medical care for patients with HIV/AIDS, 1995-2001. Can Med Assoc J. 2003;169:106-110.
20. Beck EJ, Mandalia S, Gaudreault M, et al. The cost-effectiveness of highly active antiretroviral therapy, Canada 1991-2001. AIDS. 2004;18:2411-2418.